CDC awards $200M to states to address infectious disease threats

The CDC awarded more than $200 million to states, cities, counties and territories through the Epidemiology and Laboratory Capacity for Infectious Diseases cooperative agreement to address threats created by emerging and reemerging infectious diseases.

Advertisement

The funds will be used to improve local efforts to prevent, detect and respond to public health threats created by infectious disease, including $77 million to help state health departments combat antibiotic resistance.

“More than 23,000 people in the United States die each year from infections caused by antibiotic resistance,” said Brenda Fitzgerald, MD, the director of the CDC. “CDC is committed to helping states and cities strengthen their ability to combat antibiotic resistance, and these funds will help state efforts to keep people safe.”

To learn more about the funds, click here.

More articles on infection control: 
Ebola detected in semen of survivors 2 years after infection 
Bacteria goes viral: Woman’s Facebook post claims exposure to flesh-eating bacteria at Myrtle Beach 
4 ways to support national immunization month

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

When nurses help build the AI, adoption follows: Lessons from 3 health systems

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Amy McCarthy, DNP, RNC-MNN, NE-BC, CENP, Hippocratic AIBeth Reimschissel, PhD, RN, CNL, Memorial HermannAllison Schlinkert, MSN, RN, NPD-BC, Cincinnati Children'sScott Estep, MBOE, BSN, RN, CSSBB, OhioHealth System

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.